ESTRO Anniversary GEC-ESTRO • EIOF • 11th Biennial 8-12 May, 2011 London, United Kingdom

314 Pages·2011·10.58 MB·English

ESTRO Anniversary
GEC-ESTRO • EIOF • 11th Biennial
8-12 May, 2011
London, United Kingdom
Cover image: © Sedmak - iStockphoto.com / © Killroy Productions - iStockphoto.com / © Caz - Fotolia.com / © piai - Fotolia.com / © Marina Zlochin - Fotolia.com / © Andresr - iStockphoto.com / © Alex Yeung - Foto-
lia.com / © Dragomir Uzunov - Fotolia.com
ESTRO Anniversary
GEC-ESTRO • EIOF • 11th BIENNIAL
8-12 May, 2011 • London, United Kingdom

CONTENT
Saturday, May 7, 2011
Poster discussion
PosterRapporteurSession: BreastI(Abs. 1-6)
PosterRapporteurSession: BreastII(Abs. 7-11)
PosterRapporteurSession: Sarcoma,CNS-Tumors(Abs. 12-19)
PosterRapporteurSession: Physics,Techniques,DosimetricsI(Abs. 20-25)
PosterRapporteurSession: Physics,Techniques,DosimetricsII(Abs. 26-32)
PosterRapporteurSession: GI/GUTumorsI(Abs. 33-37)
PosterRapporteurSession: GI/GUTumoursII(Abs. 38-41)
Monday, May 9, 2011
Teaching lecture
Thefutureofbrachytherapy: whatarethepotentialnewradionuclides? (Abs. 42)
Symposium
30yearsofradiationoncologyinHead&Neckcancer-Whatistheevidencethat‘we’havecreated? (Abs. 43-45)
ESTRO-ESSOJointSymposium: 30yearsofradiationoncologyinRectalcancer-Whatistheevidence-basethat
‘we’havecreated? (Abs. 46-47)
Teaching lecture
Imageregistrationinradiotherapy(Abs. 48)
Advancesinreferencedosimetry-wheredowegonext? (Abs. 49)
Impactof4DRTandRTTsrole(Abs. 50-51)
Symposium
EvolutionofMRIguidedBTincervix(Abs. 52-54)
Symposium
DosecalculationbeyondTG43: impactoncliniciansandrequirementsfromvendors(Abs. 55-58)
Head&Neckcancer-Whatistheevidencethatisbeingcreatedrightnow? -Thebestofclinicaltrials(Abs. 59-62)
ESTRO-ESSO Joint Symposium: Rectal cancer - What is the evidence-base that is being created right now? - Safetyinradiationtherapy-JointSymposiumwithPhysics(Abs. 144-146)
Thebestofclinicaltrials(Abs. 63-65)
Proffered paper
Symposium
GECProfferedPapers3: CervixCancer(Abs. 147-153)
Functionalimagingfortumourandnormaltissuecharacterization(Abs. 66-68) GECProfferedPapers4: BrachytherapyPhysics(Abs. 154-160)
Noveldosimetrymethods(Abs. 69-71)
Fromconventionaltoadvancepracticeonmiscellaneoustreatments(Abs. 72-74) Symposium
Proffered paper
ESTRO–JASTROJointSymposium: WhatisthelevelofevidenceneededinParticleTherapy? (Abs. 161-164)
GECProfferedPapers1: BreastCancer(Abs. 75-81) Proffered paper
GECProfferedPapers2: ProstateToxicity(Abs. 82-88)
ClinicalProfferedPapers2: RectalCancer(Abs. 165-170)
Symposium
PhysicsProfferedPapers3: Highlights(Abs. 171-175)
PhysicsProfferedPapers4: DoseVolumeParametersandBiologicalModelling(Abs. 176-182)
Head & Neck cancer - Vision for the future: What ‘we’ will ask for in the new grant applications? Biological and RTTProfferedPapers2: HeadandNeckCancerTreatment(Abs. 183-189)
imageguidedadaptiveradiotherapy(Abs. 89-91)
ESTRO-ESSO Joint Symposium: Vision for the future: What ‘we’ will ask for in the new grant applications? -
Translationalresearch/Hightechnology(Abs. 92-94)
Tuesday, May 10, 2011
Proffered paper
PhysicsProfferedPapers1: ResponsePrediction: GeometryandPrecision(Abs. 95-101)
Teaching lecture
PhysicsProfferedPapers2: BasicDosimetry(Abs. 102-108)
RTTProfferedPapers1: ProfessionalDevelopmentandRiskManagement(Abs. 109-115)
Publications of brachytherapy articles: overview and current trends with focus on “radiotherapy and oncology”
Award lecture (Abs. 190)
Symposium
AwardLectures(Abs. 116-118)
Symposium 30 years of radiation oncology in Lung cancer- What is the evidence that ‘we’ have created? - Update on
randomizedtrialsandMeta-analyses(Abs. 191-192)
30 years of radiation oncology in Breast cancer - What is the evidence that ‘we’ have created? - Update on
Arethere(re)newindicationsforbrachytherapy(Abs. 119-121) randomizedtrialsandMeta-analyses(Abs. 193-194)
Risks to normal tissue from current and emerging radiotherapy modalities: the results and recommendations of
theALLEGROProject(Abs. 122-126)
Teaching lecture
Newfrontiersinmetastaticcancers-SessiondevelopedincollaborationwithASCOandESMO(Abs. 127-130)
Proffered paper Volumetricimaging: adaptiveradiotherapystrategiesforclinicalimplementation(Abs. 195)
Acriticaloverviewofarctherapytechniques(Abs. 196)
Image-guidedadaptiveradiationtherapy-morethanaverificationtool(Abs. 197)
ClinicalProfferedPapers1: HeadandNeck(Abs. 131-137)
Symposium
Symposium
Thenecessityofqualityassuranceinbrachytherapy(Abs. 198-200)
Intra-fractionchallenges-Equipment(Abs. 138-140) ESTRO-ESTS-ERSJointsymposium: LungCancer-Whatistheevidencethatisbeingcreatedrightnow? -The
Newdevelopmentsandinnovativeapproaches(Abs. 141-143) bestofclinicaltrials-EarlystageNSCLC(Abs. 201-205)
Breastcancer-Whatistheevidencethatisbeingcreatedrightnow? -Thebestofclinicaltrials(Abs. 206-208)
Symposium
Symposium Symposium
Intra-fractionchallenges-predictionmodels(Abs. 209-211) Inter-fraction(betweenfractions)challenges-organdeformationandmotion(Abs. 280-282)
Symposium Symposium
QAforrotationaltherapy(Abs. 212-215) Brachytherapy-imaginganddoseadaptation. JointwithGEC-ESTRO(Abs. 283-285)
Symposium Symposium
IMRTPlanningandverification(Abs. 216-218) Functionalimagingandimagetechnology(Abs. 286-288)
Proffered paper Proffered paper
GECProfferedPapers5: Brachytherapyinanal,rectal,bladderandsofttissuesarcomas(Abs. 219-224) GECProfferedpapers7: HeadandNeck(Abs. 289-295)
GECProfferedPapers6: Prostate(Abs. 225-231) GECProfferedPapers8: GynecologicalCancer(Abs. 296-302)
Symposium Symposium
ESTRO-ESTS-ERSJointsymposium: LungCancer-Visionforthefuture: What‘we’willaskforinthenewgrant ESTRO-CAROJointSymposium: Translatingresearchinimagingintoclinicalpractice(Abs. 303-306)
applications? -Translationalresearch/Hightechnology(Abs. 232-234)
Breastcancer-Visionforthefuture: What‘we’willaskforinthenewgrantapplications? -Translationalresearch/
Proffered paper
Hightechnology(Abs. 235-237)
ClinicalProfferedPapers4: BreastCancer(Abs. 307-312)
Proffered paper
PhysicsProfferedPapers7: IMRTplanningandoptimisation(Abs. 313-319)
PhysicsProfferedPapers8: FunctionalImaging(Abs. 320-326)
PhysicsProfferedpapers5: StrategyandDevelopmentsinIGRT(Abs. 238-244) RTTProfferedPapers4: ImagingforTreatmentPlanningandPositionVerification(Abs. 327-333)
PhysicsProfferedPapers6: IGRT:4DandBreathingAdapted(Abs. 245-251)
RTTProfferedPapers3: TreatmentPlanningandDelivery(Abs. 252-258)
Award lecture
Wednesday, May 11, 2011
AwardLectures(Abs. 259-263)
Symposium
Symposium
30 years of radiation oncology in Prostate cancer - What is the evidence-based that ‘we’ have created? (Abs.
TreatmentofIntermediate-riskprostatecancerpatients(Abs. 264-266) 334-336)
EUProjects: ARTFORCEandULICE(Abs. 267-269)
Symposium
Symposium
30yearsofradiationoncology&Normaltissue-Whatistheevidencethat‘we’havecreated? (Abs. 337-338)
ESTRO-ASTROJointsymposium: Howhighprecisiontechnologywillchangeourlife(Abs. 270-273)
Teaching lecture
Proffered paper
Thetumormicro-environment(Abs. 339)
ClinicalProfferedPapers3: LungCancer(Abs. 274-279) Physicalprocessesinprotonandiontherapy(Abs. 340)
ScopeofPracticeintheNewCoreCurriculumforRTs(Abs. 341)
Howtoconvertgoodmaterialintoagoodpaperinamedicalphysicsorclinicaljournal(Abs. 342)
Symposium Presidential symposium
ESTRO-EAU Joint Symposium: Prostate Cancer - What is the evidence-based that is being created right now? ESTRO-ESMO-ESSO-ECCO Presidential symposium: Clinical Oncology: The future of Radiotherapy, Medical
Thebestofclinicaltrials(Abs. 343-346) OncologyandSurgicalOncology(Abs. 490-494)
Normaltissue-Whatistheevidence-basethatisbeingcreatedrightnow? Thebestofneededclinicaltrials(Abs.
347-350) Proffered paper
Symposium
ClinicalProfferedPapers5: Prostate&Gynaecology(Abs. 495-501)
Brachytherapy-dosimetryanddosecalculation(Abs. 351-353) Symposium
Riskassessmentanddosimetryinprotonandiontherapy(Abs. 354-356)
Clinicalauditsinradiotherapy-JointwithPhysics(Abs. 357-359)
PhDinmedicalphysics,andthen......? somein-vivoexperiences(Abs. 360-363) HighlightsinESTROPhysics(Abs. 502-504)
NormaltissuedoseresponsemodellingbeyondtheQUANTECproject(Abs. 505-507)
Symposium
Symposium
ESTRO-EAU Joint symposium: Prostate Cancer - Vision for the future: What ‘we’ will ask for in the new grant
applications? -Translationalresearch/Hightechnology(Abs. 364-366) Improvementofstaffandpatientenvironment(Abs. 508-510)
Symposium Proffered paper
Normaltissue-Visionforthefuture: What‘we’willaskforinthenewgrantapplications? -Translationalresearch/ AccessibilityofRTresourcesinEuropeandtheWorld(Abs. 511-515)
Hightechnology(Abs. 367-369) ClinicalProfferedPapers6: NormalTissueEffectsandQualityofLife(Abs. 516-521)
PhysicsProfferedPapers11: Invivoandonlinedosemeasurements(Abs. 522-528)
PhysicsProfferedPapers12: Imageregistrationandsegmentation(Abs. 529-535)
Proffered paper
RTTProfferedPapers5: PatientCare(Abs. 536-542)
PhysicsProfferedPapers8: Highlights-Smallandnon-referencefieldDosimetry(Abs. 370-376)
PhysicsProfferedPapers9: ChallengesinTreatmentPlanning(Abs. 377-383)
PhysicsProfferedPapers10: MonitoringTreatmentParameters(Abs. 384-390)
Thursday, May 12, 2011
Poster
Symposium
YoungscientistsESTROPosterSession: Trialdesignanddataanalysis(Abs. 391-397)
YoungscientistsESTROPosterSession: Treatmentplanningstudies(Abs. 398-404)
YoungscientistsESTROPosterSession: Highprecisiontechniques: stereotacticandprotons(Abs. 405-411) 30 years of radiation oncology in Gynecological cancer - What is the evidence that ‘we’ have created? – Update
YoungscientistsESTROPosterSession: IMRToptimisation(Abs. 412-418) onrandomizedtrialsandMeta-analyses(Abs. 543-545)
YoungscientistsESTROPosterSession: Radiationprotectionanddosimetry(Abs. 419-425)
YoungscientistsESTROPosterSession: IMRTVerificationandQA(Abs. 426-432)
Symposium
YoungscientistsESTROPosterSession: MonteCarlo(Abs. 433-439)
YoungscientistsESTROPosterSession: Functionalimaging(Abs. 440-446)
YoungscientistsESTROPosterSession: Radiobiologyanddosevolumeparameters(Abs. 447-453) Testis(Abs. 546-548)
YoungscientistsESTROPosterSession: IGRT4D(Abs. 454-460)
YoungscientistsESTROPosterSession: RotationalIMRT(Abs. 461-467)
Teaching lecture
YoungscientistsESTROPosterSession: Imageanalysis(segmentationandregistration)(Abs. 468-474)
YoungscientistsESTROPosterSession: IGRT(Abs. 475-481)
YoungscientistsESTROPosterSession: Radiationtechnologists(Abs. 482-487) Thecurrentstatusofstereotacticbodyradiotherapy(Abs. 549)
Developmentofproceduresforinvivodosimetryinradiotherapy(Abs. 550)
Conference lecture FocusontargetvolumedelineationoftheupperGItrack(Abs. 551-552)
Symposium
HonoraryMembersAwardLectures(Abs. 488-489)
ESTRO-ESGO Joint Symposium: Gynecological Cancer - What is the evidence-based that is being created right
now?-Thebestofclinicaltrials(Abs. 553-556) Testis(Abs. 1074-1075)
11th Biennial Physics and RTT
Interactive session
Brachytherapy: Imageguidance(Abs. 1076-1079)
Brachytherapy: planningandoptimization(Abs. 402-1086)
Ethicalissuesinmanagingoncologypatients(Abs. 557) Brachytherapy: Verificationanddosimetry(Abs. 1087-1091)
Diseasespecificissues(Abs. 1092)
Dosemeasurement: applied(1D/2D)(Abs. 1093-1096)
Symposium
Dosemeasurement: applied(3D/4D)(Abs. 1097-1100)
Dosemeasurement: basic(Abs. 1101-1111)
Incorporationofmolecularandgeneticpatternsindoseresponsemodels(Abs. 558-560) Dosemeasurement: Noveldetectors(Abs. 424-1124)
Newbeamaccelerationforprotonandiontherapy(Abs. 561-563) Dosemeasurement: smallandcompositefieldsandflatteningfree(Abs. 423-1136)
Guidelinesandprotocolsintheradiotherapydepartment(Abs. 564-566) DoseVolumeparametersandoutcomestudies(Abs. 396-1149)
ESTRO-ESGO Joint symposium: Gynecological Cancer - Vision for the future: What ‘we’ will ask for in the new Educationandtraining(Abs. 1150-1156)
grantapplications? -Translationalresearch/hightechnology(Abs. 567-570) FunctionalimagingforRTandtreatmentplanning(Abs. 440-1172)
ESTRO-EANMJointSymposium: Imaging(Abs. 571-573) IGRT:4Dimaging(Abs. 455-1182)
HowtomeettheneedsforQAinadaptiveradiotherapy? (Abs. 574-576) IGRT:Adaptivetreatmentschemesandcorrectionstrategies(Abs. 1183-1207)
Mobilityofmedicalphysicistsintheworld(Abs. 577-579) IGRT:BreathingadaptedRadiotherapy(Abs. 454-1218)
Improvingdeliveryaccuracybyusingin-roomimaging(Abs. 580-582) IGRT:Concomittantdose(Abs. 1219-1221)
IGRT:QAofimagingdevicesandgeometricaccuracy(Abs. 479-1228)
IGRT:Treatmentdeliveryandpatientpositioning(Abs. 458-1263)
Debate
IGRT:Volumedefinition,treatmentmarginsandgeometricuncertainties(Abs. 474-1280)
Imageregistration,segmentationalgorithmsanddelineation(Abs. 468-1298)
Onlinetransmissioninvivodosimetryrenderspre-treatmentQAobsolete(Abs. 583-584) IMRT:Clinicalimplementation(Abs. 1299-1308)
IMRT:Rotationaltherapies(Abs. 461-1335)
IMRT:Treatmentplanningandoptimization(Abs. 412-1358)
IMRT:TreatmentverificationandQA(Abs. 427-1383)
MCdevelopments(Abs. 1384-1387)
Posters MCforBrachy(Abs. 1388-1391)
MCfordosimetryandQA(Abs. 433-1398)
MCforTPS(Abs. 436-1407)
Patientcare(Abs. 1408-1409)
ISIORT Meeting
Patientimmobilizationandsupportaids(Abs. 483-1417)
BreastCancer((AAbbss.. 15-8559-15)91) Protonandiontherapy: Clinical(Abs. 410-1418)
GIandPelvicTumors(Abs. 592-593) Protonandiontherapy: Physics(Abs. 409-1428)
IORTTechnologies,PhysicsandBiology(Abs. 594-601) QAforIMRTandrotationaltherapytechniques(Abs. 426-1449)
Othertopics(Abs. 602-603) QA:Audit,riskmanagementandlegalissues(Abs. 484-1455)
Sarcoma,Head Neck,CNS-Tumors(Abs. 604-606) QA:Invivodosimetry(Abs. 432-1464)
QA:ofequipment(Abs. 1465-1488)
GEC-ESTRO Meeting
QA:ofsoftware(Abs. 1489-1493)
Brachytherapy: BreastCancer(Abs. 607-629) RadiationProtection(Abs. 419-1501)
Brachytherapy: Gynaecology(Abs. 630-669) Radiationtechnologists(Abs. 482-1509)
Brachytherapy: Head Neck(Abs. 670-671) Radiobiologicalmodelling(Abs. 451-1518)
Brachytherapy: Miscellaneous(Abs. 672-680) SRS-SBRT(Abs. 405-1539)
Brachytherapy: Physics(Abs. 681-696) Treatmentplanninganddosecalculation(Abs. 398-1572)
Brachytherapy: ProstateCancer(Abs. 697-730) Trials: Techniques,dosimetryandQA(Abs. 391-1584)
Brachytherapy: SkinCancer(Abs. 731-734) Undergraduate,postgraduateandcontinuouseducation(Abs. 1585-1589)
ESTRO International Oncology Forum (EIOF)
Breastcancer(Abs. 735-783)
Gynecologicalcancer(Abs. 784-807)
Head Neckcancer(Abs. 808-881)
Lungcancer(Abs. 882-902)
Lymphoma(Abs. 903-909)
Normaltissue(Abs. 910-920)
Others(Abs. 921-994)
Palliation(Abs. 995-1005)
Prostatecancer(Abs. 1006-1047)
Rectalcancer(Abs. 1048-1073)
A C
BSTRACTS ONFERENCE